As the new law rolls out, some plan sponsors are questioning whether the government's capabilities to negotiate with Medicare on lower drug prices could prompt manufacturers to increase medication costs for employer plans.
DebugScreen: mobile
{
"author": {
"name": "Sheela Andrews",
"webUrl": "/author/profile/sheela-andrews/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2023/06/09/inflation-reduction-acts-impact-on-retiree-benefits-how-employers-can-stay-ahead-of-the-curve/",
"title": "Inflation Reduction Act's impact on retiree benefits: What employers need to know",
"byline": "Sheela Andrews",
"kicker": "Expert Opinion",
"prettyDate": "June 09, 2023",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/10/olderworkersgetty-age-62.jpg",
"width": "620",
"height": "412"
},
"authors": [
{
"webUrl": "/author/profile/sheela-andrews/",
"name": "Sheela Andrews"
}
],
"kickerNode": [
{
"uri": "/expert-opinion/",
"sectionName": "Expert Opinion"
}
],
"summary": "As the new law rolls out, some plan sponsors are questioning whether the government's capabilities to negotiate with Medicare on lower drug prices could prompt manufacturers to increase medication costs for employer plans.",
"body": null
}
]
}
}